Archford Capital Strategies’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,426
| Closed | -$808K | – | 316 |
|
|
2021
Q3 | $808K | Buy |
6,426
+235
| +4% | +$29.5K | 0.19% | 136 |
|
|
2021
Q2 | $838K | Buy |
6,191
+79
| +1% | +$10.7K | 0.21% | 127 |
|
|
2021
Q1 | $816K | Buy |
6,112
+1,057
| +21% | +$141K | 0.22% | 126 |
|
|
2020
Q4 | $756K | Buy |
5,055
+1,109
| +28% | +$166K | 0.17% | 160 |
|
|
2020
Q3 | $440K | Buy |
3,946
+732
| +23% | +$81.6K | 0.12% | 184 |
|
|
2020
Q2 | $360K | Buy |
3,214
+601
| +23% | +$67.3K | 0.11% | 187 |
|
|
2020
Q1 | $202K | Buy |
+2,613
| New | +$202K | 0.08% | 207 |
|
|
2019
Q3 | – | Sell |
-650
| Closed | -$57K | – | 527 |
|
|
2019
Q2 | $57K | Hold |
650
| – | – | 0.02% | 270 |
|
|
2019
Q1 | $59K | Hold |
650
| – | – | 0.02% | 269 |
|
|
2018
Q4 | $47K | Hold |
650
| – | – | 0.02% | 269 |
|
|
2018
Q3 | $62K | Hold |
650
| – | – | 0.02% | 280 |
|
|
2018
Q2 | $62K | Hold |
650
| – | – | 0.02% | 284 |
|
|
2018
Q1 | $55K | Buy |
+650
| New | +$55K | 0.02% | 201 |
|
|
2017
Q2 | – | Sell |
-650
| Closed | -$45K | – | 634 |
|
|
2017
Q1 | $45K | Hold |
650
| – | – | 0.02% | 293 |
|
|
2016
Q4 | $38K | Hold |
650
| – | – | 0.02% | 275 |
|
|
2016
Q3 | $43K | Hold |
650
| – | – | 0.02% | 273 |
|
|
2016
Q2 | $35K | Buy |
+650
| New | +$35K | 0.02% | 285 |
|